Antibodies specific for the drkl polypeptide were used to characterize the corresponding protein in rat brain. Recombinant and synthetic immunogens containing fragments of the drkl polypeptide were produced. Antibodies raised to these immunogens display monospecific reactions with the same 130-kDa polypeptide on immunoblots of adult rat brain membranes. Immunoprecipitation of '2SI-labeled brain membranes identifies a 38-kDa peptide in tight association with the drkl polypeptide. Immunohistochemical staining of sections of adult rat cortex shows that drkl protein is restricted to neurons, where staining is present on dendrites and cell bodies but not on axons. These studies point to the value of such immunological reagents to the further characterization of the components of this delayed rectifier K+ channel in the mammalian central nervous system. Recently, a number of cDNAs have been isolated from rat brain that, when expressed in Xenopus oocytes from in vitro-transcribed mRNAs, produce IK-like currents (4-9). Among these in vitro transcription products, those from the drkl cDNA template produce currents in oocytes that most closely resemble neuronal IK in voltage-dependence and kinetics of activation, pharmacological characteristics, and lack of inactivation over tens of milliseconds (6). Thus, probes derived from the drkl cDNA could be of great use in characterizing components of neuronal IK.
Voltage-sensitive K+ channels are fundamental components in the control of excitability in neurons. Studies in a number of mammalian central neurons have identified delayed rectifier K+ currents (IK; ref. 1) . IK has been seen in >12 mammalian central nervous system preparations (2) , and some neurons contain more than one type ofdelayed outward current. Whether this diversity represents different states of a single polypeptide or different gene products is unknown. The role of IK in the mammalian central nervous system has been difficult to define; no compound is selective in blocking this conductance, and, thus, the ability to determine the behavior of neurons after blocking IK has not been feasible (3) .
Recently, a number of cDNAs have been isolated from rat brain that, when expressed in Xenopus oocytes from in vitro-transcribed mRNAs, produce IK-like currents (4) (5) (6) (7) (8) (9) . Among these in vitro transcription products, those from the drkl cDNA template produce currents in oocytes that most closely resemble neuronal IK in voltage-dependence and kinetics of activation, pharmacological characteristics, and lack of inactivation over tens of milliseconds (6) . Thus, probes derived from the drkl cDNA could be of great use in characterizing components of neuronal IK.
Biochemical characterization of K+ channel proteins has lagged behind similar studies of voltage-sensitive Na+ and Ca2+ channels. This fact is primarily due to the lack of naturally occurring high-affinity toxins for most K+ channel classes; this situation is especially true for neuronal IK. The generation of antibodies to immunogens derived from cloned K+ channel cDNAs provides an approach to characterize biochemical properties of the corresponding proteins in the absence of purified material. This report describes the use of such immunochemical reagents to begin to characterize the drkl polypeptide in adult rat brain.
MATERIALS AND METHODS
Materials. '25I-labeled protein A was from ICN, and Na'251 was from NEN. All other reagents were molecular biology grade from Sigma or Schwarz/Mann.
Production of Fusion Proteins and Antibodies. An 85-basepair (bp) insert of a drkl cDNA (pMK4; J.S.T., unpublished work) was ligated into the vector pGEX-2 (25) to create pGEXdrkl, containing amino acids 516-533 of the drkl polypeptide, which was used to immunize rabbits for production of antisera.
A synthetic peptide, KC, corresponding to the C terminus (amino acids 837-853) of the drkl polypeptide, was conjugated to keyhole limpet hemocyanin and injected into rabbits for production of antisera. A recombinant pGEX fusion protein corresponding to the C terminus of drkl polypeptide was also constructed as follows. The PCR was used to amplify a genomic fragment of drkl-coding region corresponding to nucleotides 1537-2590. A 126-bp HincII fragment (nucleotides 2465-2590, polylinker HincII site) was ligated into pGEX-2 to create pGEXKC.
Anti-pGEXdrkl, anti-glutathione-S-transferase protein from Schistosoma japonicum (sj26), and anti-pGEXKC antibodies were affinity-purified from crude antisera on nitrocellulose strips containing 1 mg of purified pGEX protein as described (10) .
Brain Membrane Preparations. A crude synaptosomal membrane fraction was prepared from freshly dissected adult rat brains by homogenization in 0.3 M sucrose/10 mM sodium phosphate, pH 7.4/1 mM EDTA containing 1 mM phenylmethylsulfonyl fluoride, leupeptin at 1 ug/ml, aprotinin at 2 jag/ml, and pepstatin at 1 ,ug/ml. This homogenate was centrifuged at 3000 x g for 10 min to remove nuclei and debris. The supernatant was centrifuged at 45,000 x g for 90 min to pellet the crude membranes. Membranes were suspended in the homogenization buffer, and protein was determined using the BCA method (Pierce). SDS/Polyacrylamide Gels and Immunoblotting. Membranes were size fractionated on 9% polyacrylamide gels (11) and transferred to nitrocellulose membranes as described (12 Neurr rProc.Nati. Acad. Sci. USA 88 (1991) 10765 For blocking experiments, antisera or affinity-purified antibodies were preincubated overnight at 40C in 1.5 ml of Blotto with fusion protein or sf26 parent protein at 35 ,ug/ml. Before use, the samples were brought to a final dilution of 1:100 with Blotto.
In Vitro Transcription and Translation. Transcription of RNA from the pDRK1/SK-(a full-length drkl cDNA provided by R. Joho, Baylor School of Medicine; ref. 5) template using T7 RNA polymerase was as described (14) . In vitro translation in rabbit reticulocyte lysates was done exactly as instructed by supplier (Promega), except that 0.1% Triton X-100 was present in the reaction mixture. lodination and Immunoprecipitation. Three milligrams of rat brain membranes was solubilized in lysis buffer (0.5% Nonidet P-40/0.15 M NaCl/1 mM EDTA/10 mM Tris HCI, pH 8.0) containing protease inhibitors for 1 hr at 40C, followed by centrifugation at 40,000 x g for 1 hr. The resultant supernatant was either used directly for immunoprecipitation (unlabeled lysate, see Fig. 4 ) or radioiodinated with 1.25 mCi of Na125I for 5 min at 40C using one lodo-Bead (Pierce). After removing the Iodo-Bead to stop the reaction, the sample was applied to a Sephadex G-10 spin column to remove unincorporated Na125I. A volume of the resultant iodinated lysate corresponding to 2 x 106 cpm ('30 pgg of protein) was used for each immunoprecipitation reaction.
"Cold" immunoprecipitates were done by using equivalent amounts of unlabeled lysate ('30 ,&g of protein). Samples were diluted to 0.9 ml with lysis buffer and precleared by incubation with fixed Staphylococcus aureus (Pansorbin, Calbiochem) for 30 min, followed by centrifugation at 10,000 x g for 30 min. Various volumes of antiserum or preimmune serum were added, and the volume was adjusted to 1 ml with lysis buffer. Samples were incubated for 1 hr at 4°C, followed by addition of fixed S. aureus, further incubation for 1 hr, and centrifugation at 10,000 x g for 1 min; the pellets were then washed five times with lysis buffer. Final pellets were resuspended in reducing sample buffer, electrophoresed on SDS/9% PAGE, and autoradiographed (for iodinated samples) or immunoblotted (for unlabeled samples).
Immunohistochemical Procedures. Deeply anesthetized animals were perfused transcardially with 0.1 M phosphatebuffered saline, pH 7.4, followed by 4% (wt/vol) paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. Brains were dissected free, postfixed in paraformaldehyde for 24 hr, and cryoprotected in 30o sucrose/0.1 M phosphate buffer before cryostat sectioning at 40 ,um.
Free-floating sections were treated with affinity-purified primary antibodies at established dilutions with 2% Triton X-100 overnight and with horseradish peroxidase-conjugated goat anti-rabbit IgG at established dilutions for 2-4 hr. Secondary antibodies were visualized with 3,3'-diaminobenzidine hydrochloride (0.03%) with H202 (0.003%). Sections were mounted on gelatinized slides, dehydrated, cleared, and coverslipped.
RESULTS
Identification of the drkl Polypeptide. Polyclonal antisera were produced by immunizing rabbits with two drkl immunogens, pGEXdrkl (amino acids 507-533) and KC (amino acids 837-853). Regions of the C-terminal cytoplasmic tail were chosen to increase the probability that drkl sequences would project from the fusion or carrier proteins as they do from drkl polypeptide. Both antisera display monospecific reactions on immunoblots of crude adult rat brain membranes with a somewhat diffuse band of 130 kDa (Fig. la, lanes A and C). Neither preimmune serum exhibited any reaction to adult rat brain membranes (Fig. la, lanes B and D) .
In vitro translation of drkl cRNA yields a 95-kDa polypeptide, showing that the increased size of rat brain drkl (Fig. 2, lane B) . Reactions to higher-molecularmass bands (=160 and 180 kDa) were not affected, indicating that these polypeptides are not related to drkl. The sf26 parent protein (pGEX-2) had no effect on KC reactivity to the 130-kDa drkl polypeptide (Fig. 2, lane C) . Anti-drkl antibodies in KC serum were affinity-purified against pGEXKC fusion protein (10). These antibodies retain their reactivity to the 130-kDa drkl polypeptide but lose their reaction to the 160-and 180-kDa bands (Fig. 2, lane D) . That the anti-130-kDa immunoreactivity of this anti-peptide serum is retained after affinity purification against a fusion protein containing fragments of drkl cDNA supports the conclusion that the 130-kDa band represents endogenous rat brain drkl polypeptide. The reaction of the affinity-purified KC antibodies to the 130-kDa drkl polypeptide is blocked by pGEXKC fusion protein (Fig. 1, lane E) but not by the pGEX parent protein (Fig. 2, lane F) .
Similarly, reaction of pGEXdrkl serum to the 130-kDa brain polypeptide was blocked by pGEXdrkl fusion protein, whereas sj26 had no effect (data not shown). ognize only sj26 and do not display reactivity to any component of the rat brain membrane preparation on these immunoblots (Fig. 3, lane B) . This result shows conclusively that the specific reaction to the 130-kDa protein in brain membranes is from antibodies in the serum that recognize the part of the fusion protein derived from drkl polypeptide and not to antibodies in the serum that recognize sf26 parent protein.
To was done on detergent lysates of brain membranes. The immunoprecipitation product was analyzed on immunoblots using either pGEXdrkl or KC antiserum. Fig. 4 shows that the brain protein immunoprecipitated by KC antiserum displays immunoreactivity with both KC and pGEXdrkl sera. Identification of Neuronal Proteins Interacting with drkl K+ Channel in Brain. To determine whether other proteins associate with the 130-kDa drkl polypeptide, immunoprecipitations were done on radiolabeled detergent lysates of adult rat brain membranes under the same conditions used for the experiment of Fig. 4 . Immunoprecipitation with increased amounts of KC serum yields increased amounts of the 130-kDa drkl polypeptide (Fig. 5) , corresponding to the KC immunoprecipitation product detected by immunoblotting with KC or pGEXdrkl sera (Fig. 4) . No 130-kDa drkl polypeptide was precipitated by the preimmune serum at any dilution, although an 80-kDa protein was precipitated nonspecifically by both immune and preimmune sera (Fig. 5) .
Surprisingly, a second peptide of 38 kDa is specifically precipitated by KC immune serum (Fig. 5) . The amount of 38-kDa peptide in the immunoprecipitate parallels the levels of 130-kDa drkl polypeptide. As shown above, neither KC nor pGEXdrkl antiserum recognize the 38-kDa polypeptide on immunoblots of these same membranes (Figs. la, 2, and 3) or on immunoblots of immunoprecipitated drkl complexes (Fig. 4) . These results show that the 38-kDa protein is immunologically distinct from the drkl polypeptide, suggesting that specific precipitation of the 38-kDa polypeptide is from interaction of this protein with the immunoreactive 130-kDa polypeptide.
Localization of drkl Polypeptide in Rat Cortex. Cellular localization of the drkl protein in brain was determined to better correlate distribution of this delayed rectifier isoform to K+ conductance pathways previously identified in neurons and glia. The drkl cDNA was isolated from a whole-brain library (6); thus, it was unknown whether this channel isoform was present in neurons or glia. Fig. 6A shows that anti-drkl labeling in adult cortex is detected only in the membranes of cell bodies and dendrites of a subpopulation of cortical neurons. No detectable staining is seen to glial cells. Fig. 6B shows a higher magnification of the same field that demonstrates that the immunoreactivity is prominent on both apical and distal dendrites of a large pyramidal cell. This figure also demonstrates the punctate, membrane-associated nature of the staining. Similar expression cloning in Xenopus oocytes (6 (16) and the acetylcholine (17) and glycine (18) receptors. The interaction between the drkl and 38-kDa polypeptides is noncovalent, as the drkl polypeptide does not change mobility upon reduction of disulfide bonds. All procedures involved in these analyses were done at 4°C with protease inhibitor mixtures; however, the 38-kDa peptide could be a proteolytic fragment of the drkl polypeptide that remains associated during the immunoprecipitation procedure. Further molecular characterization of the coprecipitating 38-kDa peptide will be needed to determine its relationship to the drkl polypeptide and its role in the quaternary structure of the drkl channel oligomeric complex.
Interestingly, the one class of K+ channels amenable to biochemical characterization-those sensitive to the epileptogenic neurotoxins dendrotoxin and p-bungarotoxin-are also formed as a oligomeric complex containing an a-peptide and a 38-kDa protein (19, 20 a-peptides expressed in Xenopus oocytes have shown that heterooligomers can be formed with different a-peptides. It is not clear whether such structures exist in situ, although electrophysiological evidence suggests that in heterologous expression systems some K+ channels are formed as homotetramers of a-peptides (23) . drkl is unusual among K+ channel polypeptides in its large size; thus, it should be possible to detect other K+ channel polypeptides (50-70 kDa) in the drkl immunoprecipitation products. The absence of other K+ channel-sized polypeptides in the immunoprecipitates could be from disruption of heteromultimeric complexes during immunoprecipitation procedures or by poor labeling of other K+ channel a-peptides present in drkl complexes by radioiodination. However, this result could also mean that the predominant drkl channel complexes exist as homotetramers of the drkl polypeptide, perhaps in association with the 38-kDa peptide.
drkl Is Expressed in Neurons. Delayed rectifier-like K+ currents have been found in both mammalian central neurons and glial cells. All mammalian neuronal K+ channel cDNAs isolated to date have come from libraries derived from both neurons and glia. Cellular localization of protein components of any of these K+ channels has yet to be determined. The cDNA encoding drkl polypeptide was originally isolated from a library prepared from whole adult rat brain mRNA (6) and, thus, contained cDNAs encoding both neuronal and glial K+ channels.
Immunocytochemical localization of the drkl polypeptide in the adult rat cortex shows that at the detection level by immunocytochemistry, drkl polypeptide is specific to neurons; no detectable staining was seen in glial cells. The finding that the drkl polypeptide is preferentially expressed in neurons is essential to any eventual correlation of the role of the corresponding channel in a specific neuronal K+ conductance pathway. Localization of Shaker channels in Drosophila brain (24) revealed that these K+ channel a-peptides are not uniformly distributed within the fly nervous system and that they are found in nerves composed of axons as well as in regions rich in synapses.
The drkl-specific staining was cell-surface-associated in these cortical neurons, supporting the premise that the drkl polypeptide plays a role in surface K+ conductance pathways in the plasma membrane. drkl immunoreactivity appears localized to the cell bodies and proximal dendrites of these neurons. It is not clear whether this immunoreactivity represents postsynaptic staining on these neurons or presynaptic staining on the nerve terminals that cover these cells. A more detailed understanding of the subcellular distribution of the drkl polypeptide will require EM.
The results presented here provide information on the biochemical characteristics of the endogenous drkl-delayed rectifier K+ channel in adult rat brain. The antibodies employed in this study should be useful tools to characterize further the biochemical properties, biosynthesis, and distribution of this neuronal delayed rectifier K+ channel. These antibodies will be especially helpful in isolating drkl for chemical analysis after treatment of neurons with modulators of neuronal delayed rectifier currents, such as protein kinase C. In addition, a description of the biosynthesis, processing, assembly, surface appearance, and turnover of drkl channel components will lead to a better understanding of the processes that control surface channel abundance and distribution. These antibodies should also prove useful in purifying neuronal drkl channel complexes to isolate and determine the structural and functional contributions of channel components other than the a-peptide. 
